WattjesMPRoviraAMillerDet al. MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis – Establishing disease prognosis and monitoring patients. Nat Rev Neurol2015; 11: 597–606.
2.
ZeccaCDisantoGSormaniMPet al. Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis. Mult Scler2016; 22(6): 782–791.
3.
ThorpeJWKiddDMoseleyIFet al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain1996; 119(Pt 3): 709–714.
4.
BotJBarkhofFPolmanCHet al. Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination. Neurology2004; 62(2): 226–233.
5.
BrownleeWJAltmannDRDa MotaPAet al. Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome. Mult Scler2017; 23(5): 665–674.
6.
ArrambideGRoviraASastre-GarrigaJet al. Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler2018; 24(3): 301–312.
7.
SombekkeMHWattjesMPBalkLJet al. Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis. Neurology2013; 80: 69–75.
8.
PatruccoLRojasJICristianoE.Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes. J Neurol2012; 259: 1317–1320.
9.
KearneyHAltmannDRSamsonRSet al. Cervical cord lesion load is associated with disability independently from atrophy in MS. Neurology2015; 84(4): 367–373.
10.
KantarciOHLebrunCSivaAet al. Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol2016; 79(2): 288–294.
